Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education



Front Page

World

UK

UK Politics

Business

Sci/Tech

Health

Education

Sport

Entertainment

Talking Point
On Air
Feedback
Low Graphics
Help

Thursday, November 12, 1998 Published at 16:32 GMT


Business: The Company File

Zeneca mulls specialities sale



British drug giant Zeneca has said it is considering selling off its specialities business.

Zeneca Specialties includes biocides, industrial colours, lifescience molecules, performance and intermediate chemicals and resins.

The company said the move would offer the business additional growth opportunities in the rapidly expanding speciality chemicals sector.

Chief executive David Barnes said the sale could be completed in the first quarter of next year.

"I would hope that we would have completed the deal in quarter one...It's not likely that we will be making any announcement before the turn of the year," he said.


[ image: Zeneca's agrochemicals business is not for sale]
Zeneca's agrochemicals business is not for sale
The business operates across 35 sites worldwide and employs about 5,500 people.

It accounted for £434m ($719.5m) of Zeneca's total first half sales of £2.9bn.

Zeneca said that its Marlow Foods business would not be included in any sale.

Its northern England Huddersfield works, excluding dedicated specialities' plants, and the company's agrochemicals plants at Grangemouth in Scotland will also remain with Zeneca.

Shares in the company were trading 25p higher at 2280p after moving in negative territory ahead of the statement.

Analysts welcome sale

Analysts pointed out that the sale did not include Zeneca's agrochemicals operations, still seen as a growth area.

However they welcomed the sale as a move out of a relatively low-margin business and as providing Zeneca with a useful cash boost.

Analysts said they expected the businesses to fetch double their sales of around £800m - a sale price of £1.6bn.

Some also said the move would make Zeneca more attractive as a possible merger partner.

Jeremy Scudamore, chief executive of Zeneca Specialties, said he expected the business to fetch a good price but would not comment on analyst predictions.

"This is not a fire sale. This is an extremely high quality group of businesses which will enhance any of the reputable first division leaders in specialty chemicals," he said.

"We're not interested in people who want to break it up or people who want to cherry-pick," he added.





  • Advanced options | Search tips




    Back to top | BBC News Home | BBC Homepage | ©


  • The Company File Contents


    Relevant Stories

    27 Oct 98 | The Company File
    Zeneca warns over pound's strength

    06 Aug 98 | The Company File
    Pound batters drug giant





    Internet Links


    Zeneca


    The BBC is not responsible for the content of external internet sites.




    In this section

    Microsoft trial mediator welcomed

    Vodafone takeover battle heats up

    Christmas turkey strike vote

    NatWest bid timetable frozen

    France faces EU action over electricity

    Pace enters US cable heartland

    Mannesmann fights back

    Storehouse splits up Mothercare and Bhs

    The rapid rise of Vodafone

    The hidden shopping bills

    Europe's top net stock

    Safeway faces cash demand probe

    Mitchell intervenes to help shipyard

    New factory creates 500 jobs

    Drugs company announces 300 jobs

    BT speeds internet access

    ICL creates 1,000 UK jobs

    National Power splits in two

    NTT to slash workforce

    Scoot links up with Vivendi

    New freedom for Post Office

    Insolvent firms to get breathing space

    Airtours profits jump 12%

    Freeserve shares surge

    LVMH buys UK auction house

    Rover - a car firm's troubles